Recombinant Human Integrin alpha 2B beta 3 Protein，His

Integrin alpha 2B beta 3, also known as glycoprotein IIb/IIIa, is a crucial receptor found on the surface of platelets, playing a vital role in hemostasis and thrombosis. This heterodimeric protein is responsible for binding fibrinogen and other adhesive proteins, facilitating platelet aggregation during clot formation. The study of recombinant integrin alpha 2B beta 3 has garnered significant interest due to its implications in cardiovascular diseases, particularly in the development of antithrombotic therapies. Understanding the structure and function of this integrin can lead to the design of novel inhibitors that target its active sites, which are essential for platelet aggregation. Research has highlighted the significance of different conformational states of alpha 2B beta 3 in regulating its activity and interaction with ligands. Additionally, recombinant production of this integrin enables detailed biochemical and biophysical characterization, providing insights into its signaling mechanisms and the molecular basis of integrin-mediated cell adhesion. With the increasing prevalence of cardiovascular disorders, the development of integrin-targeting therapeutics based on recombinant alpha 2B beta 3 offers a promising approach to mitigating the risks associated with thrombotic events. Therefore, ongoing studies focused on the isolation, purification, and functional analysis of recombinant alpha 2B beta 3 are critical for advancing our understanding of platelet biology and improving clinical strategies for thromboembolic diseases.